Senior insider sale
President and CEO at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$2.83M
200K shares
What this filing means
LOWENTHAL RICHARD E plans to sell 200K shares of ARS PHARMACEUTICALS, INC. valued at approximately $2.83M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2025ACC: 0001949846-25-000399
DirectorOfficer10% Owner· President and CEO
Since Nov 2022
200K
Shares to sell
$2.83M
Approx. market value
150K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
FOUNDERS AND SERIES A SHRS
N/A
9/25/2015
150KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2015 | FOUNDERS AND SERIES A SHRS N/A | 150K | — |
| Total | 150K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
37.66K
Market value
$530.6K
8/20/2025
—Completed
Units to sell
12.34K
Market value
$173.1K
8/19/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
150K
Market value
$2.12M
8/21/2025
Total
Units
200K
Value
$2.83M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/20/2025 | 37.66K | $530.6K | — | Completed |
8/19/2025 | 12.34K | $173.1K | — | Completed |
| Planned — Approximate Date | ||||
8/21/2025 | 150K | $2.12M | NASDAQ | Planned |
| Total | 200K | $2.83M | ||